Alterations in the permeability of dystrophic fibers during neuromuscular junction development

Area of Science:

• Muscle Physiology
• Neuromuscular Biology
• Duchenne Muscular Dystrophy Research

Background:

• Duchenne muscular dystrophy (DMD) in mdx mice involves dystrophin deficiency, leading to increased calcium influx, myonecrosis, and faster synapse elimination.
• The role of myofiber membrane permeability and sarcolemmal damage in the developmental aspects of neuromuscular junctions in DMD is not fully understood.

Purpose of the Study:

• To investigate changes in myofiber permeability using Evans Blue Dye (EBD) in mdx mice during neuromuscular junction development.
• To determine if increased sarcolemmal permeability correlates with the accelerated synapse elimination observed in dystrophic muscle.

Main Methods:

• Intraperitoneal injection of Evans Blue Dye (EBD) in mdx and control mice at various developmental time points (1, 7, 14, and 21 days, and adult).
• Analysis of sternomastoid (STN) and tibialis anterior (T. anterior) muscles using fluorescence microscopy to detect EBD-positive myofibers.
• Correlation of EBD labeling with developmental stages of the neuromuscular junction.

Main Results:

• No EBD staining was observed in mdx myofibers at 1, 7, or 14 days of age.
• Positive EBD labeling, indicating myofiber permeability and myonecrosis, was detected in mdx tibialis anterior and sternomastoid muscles at 21 days of age.
• Adult mdx muscles showed decreased (T. anterior) or unchanged (STN) EBD-positive fibers compared to younger stages.

Conclusions:

• Evans Blue Dye staining does not detect sarcolemmal damage during the early development of neuromuscular junctions in mdx mice.
• The observed myofiber permeability and myonecrosis at 21 days suggest a developmental window of membrane instability.
• These findings imply that factors other than sarcolemmal damage detectable by EBD likely contribute to the accelerated synapse elimination in dystrophic muscle.